Article Details

SoftBank leads funding that could net up to $525M for Exscientia's AI drug platform

Retrieved on: 2021-04-28 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

SoftBank leads funding that could net up to $525M for Exscientia's AI drug platform. View article details on hiswai:

Excerpt

SoftBank Vision Fund 2 led the $225 million series D financing, in which a dozen other investors participated, including BlackRock, Novo Holdings, ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo